Wells Fargo
TMCI icon

Wells Fargo’s Treace Medical Concepts TMCI Stock Holding History

Wells Fargo’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,543
Closed -$23.5K – 7596
2026
Q1 		$23.5K Sell
17,543
-34,620
-66% -$69K ﹤0.01% 5714
2025
Q4 		$128K Buy
52,163
+20,870
+67% +$90.6K ﹤0.01% 5285
2025
Q3 		$210K Buy
31,293
+4,647
+17% +$30.3K ﹤0.01% 4908
2025
Q2 		$157K Buy
26,646
+591
+2% +$3.85K ﹤0.01% 4909
2025
Q1 		$219K Buy
26,055
+1,259
+5% +$11.3K ﹤0.01% 4642
2024
Q4 		$184K Buy
24,796
+7,769
+46% +$52K ﹤0.01% 4842
2024
Q3 		$98.8K Sell
17,027
-2,188
-11% -$14.1K ﹤0.01% 5030
2024
Q2 		$128K Buy
19,215
+3,591
+23% +$29K ﹤0.01% 4797
2024
Q1 		$204K Buy
15,624
+2,959
+23% +$39.4K ﹤0.01% 4461
2023
Q4 		$161K Buy
12,665
+2,119
+20% +$21.4K ﹤0.01% 4608
2023
Q3 		$138K Sell
10,546
-10,545
-50% -$193K ﹤0.01% 4587
2023
Q2 		$540K Buy
21,091
+11,011
+109% +$284K ﹤0.01% 3897
2023
Q1 		$254K Buy
10,080
+9,022
+853% +$212K ﹤0.01% 4296
2022
Q4 		$24.3K Sell
1,058
-16,107
-94% -$371K ﹤0.01% 5181
2022
Q3 		$379K Buy
17,165
+16,195
+1,670% +$313K ﹤0.01% 3867
2022
Q2 		$14K Sell
970
-27,145
-97% -$457K ﹤0.01% 5620
2022
Q1 		$531K Sell
28,115
-6,523
-19% -$127K ﹤0.01% 4360
2021
Q4 		$646K Sell
34,638
-78,689
-69% -$1.62M ﹤0.01% 4462
2021
Q3 		$3.05M Buy
113,327
+39,814
+54% +$1.1M ﹤0.01% 3301
2021
Q2 		$2.3M Buy
+73,513
New +$2.34M ﹤0.01% 3564

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wells Fargo's TMCI Position: Q2 2026 in Review

Wells Fargo sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 17,543 shares — an estimated $23.5K sold.

Wells Fargo first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $3.05M in Q3 2021. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Wells Fargo reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 17,543 Treace Medical Concepts shares in Q2 2026, an estimated $23.5K.
  • Wells Fargo first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
  • Wells Fargo's Treace Medical Concepts position peaked at $3.05M in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.